| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Glenview Capital · Larry Robbins | $418.2M | 7.62% | 2.24M | +47% | Q2 2026 |
| Bridgewater Associates · Ray Dalio | $7.9M | 0.03% | 42.38K | +126% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| Jonathan Jackson IL01 | 2 | 3 | −$8.0K | Sold Apr 20, 26 |
| Lisa McClain MI09 | 1 | 1 | +$0 | Sold Aug 4, 25 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Apr 20, 26 | Jonathan Jackson IL01 | Joint | Sell | $15,001 - $50,000 | May 27, 26 (37d) | |
| Apr 15, 26 | Jonathan Jackson IL01 | Spouse | Sell | $1,001 - $15,000 | May 27, 26 (42d) | |
| Feb 11, 26 | Jonathan Jackson IL01 | Spouse | Sell (part) | $1,001 - $15,000 | Mar 12, 26 (29d) | |
| Dec 10, 25 | Jonathan Jackson IL01 | Joint | Buy | $15,001 - $50,000 | Jan 8, 26 (29d) | |
| Sep 3, 25 | Jonathan Jackson IL01 | Spouse | Buy | $1,001 - $15,000 | Oct 15, 25 (42d) | |
| Aug 4, 25 | Lisa McClain MI09 | Spouse | Sell | $1,001 - $15,000 | Sep 12, 25 (39d) | |
| Jun 11, 25 | Lisa McClain MI09 | Spouse | Buy | $1,001 - $15,000 | Aug 13, 25 (63d) |
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 13, 2026 | Kerrey Joseph RobertDirector | Sale at price 263.04 - 264.62 per share. | 12K | $3.17M |
| Sep 9, 2026 | Mark Richard JDirector | Sale at price 263.42 per share. | 10K | $2.63M |
| Sep 1, 2026 | West Nadja Y.Director | Sale at price 258.80 per share. | 1.2K | $298.14K |
| Aug 30, 2026 | Foo Lisa YChief Operating Officer | Sale at price 266.32 per share. | 24K | $6.39M |
| Aug 27, 2026 | Haney Cecil D.Director | Stock Gift at price 0.00 per share. | 150 | — |
| Aug 24, 2026 | Sutaria SaumyaChief Executive Officer | Sale at price 273.34 - 278.90 per share. | 100K | $27.64M |
| Aug 23, 2026 | Haney Cecil D.Director | Sale at price 278.03 per share. | 1.3K | $361.44K |
| Aug 6, 2026 | Romo TammyDirector | Sale at price 260.83 - 264.15 per share. | 7.4K | $1.95M |
| Aug 4, 2026 | Blunt RoyDirector | Sale at price 262.68 per share. | 600 | $157.61K |
| Jul 28, 2026 | Foo Lisa YChief Operating Officer | Sale at price 258.03 per share. | 10K | $2.58M |
| Jul 26, 2026 | Lynch Christopher SDirector | Sale at price 243.44 per share. | 3.8K | $934.08K |
| Jul 26, 2026 | Arbour Paola MChief Technology Officer | Sale at price 243.90 per share. | 10.9K | $2.65M |
| Jul 26, 2026 | Bierman James LDirector | Sale at price 244.96 per share. | 5K | $1.22M |
| May 27, 2026 | Kerrey Joseph RobertDirector | Sale at price 173.12 - 177.52 per share. | 5.6K | $983.92K |
| May 26, 2026 | West Nadja Y.Director | Sale at price 177.35 per share. | 3K | $532.05K |
| May 21, 2026 | Lynch Christopher SDirector | — | 1.3K | — |
| May 21, 2026 | Romo TammyDirector | — | 1.3K | — |
| May 21, 2026 | Haney Cecil D.Director | — | 1.3K | — |
| May 21, 2026 | Kerrey Joseph RobertDirector | — | 1.6K | — |
| May 21, 2026 | Mark Richard JDirector | — | 1.3K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.8 | 26.5 | -21.2 | -6.1 | -1.0 | 6.7 | 36.2 | 4.4 | -3.9 | 4.7 | +34.6% | ||
| 2025 | 11.6 | -10.1 | 6.2 | 6.3 | 18.1 | 4.3 | -8.4 | 14.3 | 10.2 | 1.7 | 5.0 | -8.4 | +57.4% |
| 2024 | 9.5 | 12.4 | 13.0 | 6.8 | 20.4 | -1.6 | 12.5 | 10.8 | 0.2 | -6.7 | -8.0 | -11.5 | +67.0% |
| 2023 | 12.4 | 6.7 | 1.5 | 23.4 | -2.9 | 14.3 | -8.2 | 3.8 | -15.0 | -18.5 | 28.5 | 9.5 | +54.9% |
| 2022 | -9.3 | 16.0 | -0.0 | -15.6 | -10.8 | -18.8 | 25.8 | -14.5 | -8.7 | -14.0 | 4.1 | 5.7 | −40.3% |
| 2021 | 18.4 | 7.9 | 1.9 | 14.0 | 12.9 | 0.1 | 7.2 | 4.9 | -11.8 | 7.9 | 1.7 | 12.1 | +104.6% |
| 2020 | -16.8 | -16.9 | -45.2 | 40.1 | 7.8 | -16.8 | 46.0 | 6.6 | -13.0 | 0.1 | 28.1 | 27.0 | +5.0% |
| 2019 | 28.3 | 30.0 | 0.9 | -24.1 | -8.9 | 3.5 | 14.1 | -8.1 | 2.2 | 14.6 | 27.1 | 18.1 | +121.9% |
| 2018 | 24.5 | 9.1 | 17.7 | -1.3 | 48.0 | -5.2 | 12.1 | -10.4 | -15.6 | -9.6 | 1.3 | -34.3 | +13.1% |
| 2017 | 18.5 | 9.7 | -8.2 | -11.5 | 5.6 | 16.9 | -10.3 | -1.0 | -4.3 | -13.1 | -1.3 | 7.5 | +2.2% |
| 2016 | -10.5 | -8.5 | 16.6 | 9.5 | -8.7 | -4.5 | 10.7 | -21.9 | -5.2 | -13.0 | -22.7 | -2.6 | −51.0% |
| 2015 | -16.6 | 9.5 | 6.9 | -3.3 | 11.1 | 8.8 | -2.7 | -12.6 | -25.0 | -15.0 | 5.8 | -8.7 | −40.2% |
| 2014 | 9.2 | -4.1 | -3.0 | 5.3 | 4.3 | -0.1 | 12.4 | 15.9 | -2.9 | -5.6 | -14.3 | 5.5 | +20.3% |
| 2013 | 19.6 | 1.2 | 21.0 | -4.7 | 4.4 | -2.7 | -3.1 | -12.5 | 5.5 | 14.6 | -8.6 | -2.4 | +29.7% |
| 2012 | 3.1 | 6.8 | -6.0 | -2.3 | -9.2 | 11.3 | -11.8 | 12.3 | 20.8 | -5.9 | 22.7 | 12.1 | +58.2% |
| 2011 | -0.6 | 8.0 | 3.8 | -7.0 | -7.9 | -2.2 | -10.9 | -5.0 | -22.2 | 15.1 | -1.7 | 10.3 | −23.3% |
| 2010 | 2.8 | -4.9 | 8.5 | 9.3 | -8.5 | -24.1 | 6.0 | -14.8 | 20.4 | -7.6 | -6.4 | 64.0 | +24.1% |
| 2009 | -7.0 | 3.7 | 4.5 | 94.0 | 61.3 | -22.3 | 40.1 | 18.0 | 26.2 | -12.9 | -11.1 | 18.5 | +368.7% |
| 2008 | -13.4 | 9.3 | 17.7 | 13.1 | -7.8 | -5.8 | 4.1 | 4.1 | -8.0 | -21.1 | -72.4 | -5.0 | −77.4% |
| 2007 | 1.3 | -3.4 | -5.7 | 15.4 | -6.3 | -6.3 | -20.4 | -34.6 | -0.9 | 4.5 | 57.0 | -7.8 | −27.1% |
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services through heart, liver, and kidney transplants programs; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
Buy / hold / sell counts